Assessing the Commercial Potential of Oncology Assets

EventBrite Image

Forecasting commercial potential in oncology markets involves some unique challenges. Determining the appropriate patient populations and their numbers requires reliable data sources. In-depth knowledge of definitions and treatment paradigms is also an important element. Addressing the cascade of patients through lines of therapies is complex. New therapies addressing various biomarkers and patient segments may mean forecasting a single tumor would lead to creating many different forecasts.

During these one-day sessions, join Kantar Health for this opportunity to increase your confidence by expanding and sharpening your oncology forecasting skills and knowledge. The same material will be covered each day, so choose which date is best for you.

Through a blend of instruction on forecasting theory and hands-on application, this interactive session will guide you through the steps of building powerful oncology forecasting models. You will take home practical knowledge, forecasting tools, and proven ideas that you can use every day.

Key topics discussed during the interactive workshop include:

  • Overview of oncology treatment paradigm
  • Overview of oncology market and trends
  • Oncology biomarkers
  • Cross-sectional versus patient flow modeling
  • The oncology forecasting process
  • Building oncology forecasts using Excel
  • Oncology Epidemiology
  • Building assumptions & completing the commercial assessment
  • Pricing & Reimbursement

The workshops are appropriate for forecasters, marketing managers, business insight managers, BD&L managers or more experienced oncology forecasting professionals who may wish to learn the Kantar Health methodology to enhance their skill set and update their knowledge about current trends and advances in the industry.

Registrations are transferable and cannot be canceled.